[Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany]

Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Feb;40(2):85-90. doi: 10.1055/s-2004-825874.

[Article in German]

Authors

E Meyer¹, W Ebner, A Heininger, F Schwab, H Rüden, F D Daschner

Affiliation

¹ Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinikum Freiburg. [email protected]

PMID: 15714398
DOI: 10.1055/s-2004-825874

No abstract available

MeSH terms

Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Bronchoalveolar Lavage Fluid / microbiology
Cephalosporins / therapeutic use
Community-Acquired Infections / drug therapy*
Community-Acquired Infections / epidemiology
Community-Acquired Infections / microbiology*
Cross Infection / drug therapy*
Cross Infection / epidemiology
Cross Infection / microbiology*
Drug Resistance, Bacterial
Enzyme Inhibitors / pharmacology
Germany / epidemiology
Guidelines as Topic
Humans
Intensive Care Units
Penicillins / therapeutic use
Piperacillin / therapeutic use
Pneumonia / drug therapy*
Pneumonia / epidemiology
Pneumonia / microbiology*
Population Surveillance
Respiration, Artificial / adverse effects
Surveys and Questionnaires
beta-Lactamase Inhibitors

Substances

Anti-Bacterial Agents
Cephalosporins
Enzyme Inhibitors
Penicillins
beta-Lactamase Inhibitors
Piperacillin